{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:01:16Z","timestamp":1792839676140,"version":"4.5.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver Transpl"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>Acute severe presentations of autoimmune hepatitis (AIH) represent a challenge for the transplant community. As a disease, it is poorly characterized, and there is a weak evidence base to guide diagnosis and treatment. Early identification of acute severe AIH is key because it determines the initiation of corticosteroids, which can be lifesaving. However, their use in this setting remains controversial. The Model for End\u2010Stage Liver Disease score, severity of coagulopathy, and grade of encephalopathy may be predictors of outcome with corticosteroid therapy. The optimal timing of liver transplantation (LT) can be difficult to determine and, as such, the decision to proceed to transplantation should not be delayed by protracted courses of corticosteroids. The aim of this review is to better characterize this subset of patients; to differentiate them clinically, serologically, and histologically from chronic AIH and other causes of acute liver failure; and to present the role, predictors, and optimal timings of corticosteroid therapy and LT. Although this review is specific to adults, many principles hold true for the pediatric population.<\/jats:p>","DOI":"10.1002\/lt.25451","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T07:09:55Z","timestamp":1553238595000},"page":"946-959","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation?"],"prefix":"10.1097","volume":"25","author":[{"given":"Mussarat N.","family":"Rahim","sequence":"first","affiliation":[{"name":"Institute of Liver Studies,King\u2019s College Hospital National Health Service Foundation Trust,London,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Liberal","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies,King\u2019s College Hospital National Health Service Foundation Trust,London,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Miquel","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies,King\u2019s College Hospital National Health Service Foundation Trust,London,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel D.","family":"Heaton","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies,King\u2019s College Hospital National Health Service Foundation Trust,London,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies,King\u2019s College Hospital National Health Service Foundation Trust,London,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"lt25451-bib-0001-20240115","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","year":"2013","journal-title":"Lancet"},{"key":"lt25451-bib-0002-20240115","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.25551","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011","volume":"55","year":"2012","journal-title":"Hepatology"},{"key":"lt25451-bib-0003-20240115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0140-6736(93)91818-7","article-title":"Acute liver failure: redefining the syndromes","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"lt25451-bib-0004-20240115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","year":"2013","journal-title":"Dig Dis Sci"},{"key":"lt25451-bib-0005-20240115","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","article-title":"Prognosis of acute severe autoimmune hepatitis (AS\u2010AIH): the role of corticosteroids in modifying outcome","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"lt25451-bib-0006-20240115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"lt25451-bib-0007-20240115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"lt25451-bib-0008-20240115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hch072","article-title":"Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type","volume":"97","year":"2004","journal-title":"QJM"},{"key":"lt25451-bib-0009-20240115","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","article-title":"The nature and prognostic implications of autoimmune hepatitis with an acute presentation","volume":"21","year":"1994","journal-title":"J Hepatol"},{"key":"lt25451-bib-0010-20240115","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug\u2010induced liver injury","volume":"54","year":"2011","journal-title":"Hepatology"},{"key":"lt25451-bib-0011-20240115","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug\u2010induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"lt25451-bib-0012-20240115","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2007.05.011","article-title":"The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study","volume":"47","year":"2007","journal-title":"J Hepatol"},{"key":"lt25451-bib-0013-20240115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug\u2010induced liver injury","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"lt25451-bib-0014-20240115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1752-1947-4-311","article-title":"Autoimmune hepatitis triggered by nitrofurantoin: a case series","volume":"4","year":"2010","journal-title":"J Med Case Rep"},{"key":"lt25451-bib-0015-20240115","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/BF01307513","article-title":"A double\u2010blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group","volume":"36","year":"1991","journal-title":"Dig Dis Sci"},{"key":"lt25451-bib-0016-20240115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.26678","article-title":"Steroid use in acute liver failure","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"lt25451-bib-0017-20240115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000322298","article-title":"Steroid and ursodesoxycholic Acid combination therapy in severe drug\u2010induced liver injury","volume":"84","year":"2011","journal-title":"Digestion"},{"key":"lt25451-bib-0018-20240115","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cgh.2017.05.027","article-title":"Drug\u2010induced autoimmune hepatitis: response to corticosteroids and lack of relapse after cessation of steroids","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"lt25451-bib-0019-20240115","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/ijc.30678","article-title":"Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta\u2010analysis of published data","volume":"141","year":"2017","journal-title":"Int J Cancer"},{"key":"lt25451-bib-0020-20240115","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/COC.0000000000000374","article-title":"Hepatotoxicity after immune checkpoint inhibitor therapy in melanoma: natural progression and management","volume":"41","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"lt25451-bib-0021-20240115","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2012.41.6750","article-title":"Management of immune\u2010related adverse events and kinetics of response with ipilimumab","volume":"30","year":"2012","journal-title":"J Clin Oncol"},{"key":"lt25451-bib-0022-20240115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti\u2010CTLA\u20104 treatment (CheckMate 037): a randomised, controlled, open\u2010label, phase 3 trial","volume":"16","year":"2015","journal-title":"Lancet Oncol"},{"key":"lt25451-bib-0023-20240115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"lt25451-bib-0024-20240115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jhep.2016.11.015","article-title":"Managing immune checkpoint\u2010inhibitor\u2010induced severe autoimmune\u2010like hepatitis by liver\u2010directed topical steroids","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"lt25451-bib-0025-20240115","doi-asserted-by":"crossref","first-page":"e000268","DOI":"10.1136\/esmoopen-2017-000268","article-title":"Severe steroid\u2010resistant anti\u2010PD1 T\u2010cell checkpoint inhibitor\u2010induced hepatotoxicity driven by biliary injury","volume":"2","year":"2017","journal-title":"ESMO Open"},{"key":"lt25451-bib-0026-20240115","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","article-title":"Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis","volume":"64","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"lt25451-bib-0027-20240115","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/MCG.0b013e3181a745e7","article-title":"Adalimumab\u2010induced autoimmune hepatitis","volume":"44","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"lt25451-bib-0028-20240115","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1200\/JCO.2010.32.2206","article-title":"Resolution of severe ipilimumab\u2010induced hepatitis after antithymocyte globulin therapy","volume":"29","year":"2011","journal-title":"J Clin Oncol"},{"key":"lt25451-bib-0029-20240115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jjco\/hyw167","article-title":"Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab","volume":"47","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"lt25451-bib-0030-20240115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40425-015-0066-0","article-title":"Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation","volume":"3","year":"2015","journal-title":"J Immunother Cancer"},{"key":"lt25451-bib-0031-20240115","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/annonc\/mdx281","article-title":"Acute liver graft rejection after ipilimumab therapy","volume":"28","year":"2017","journal-title":"Ann Oncol"},{"key":"lt25451-bib-0032-20240115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0041-3879(76)80003-7","article-title":"Polyarthritis, hepatitis and anti\u2010native DNA antibodies after treatment with ethambutol and rifampicin","volume":"57","year":"1976","journal-title":"Tubercle"},{"key":"lt25451-bib-0033-20240115","first-page":"5741896","article-title":"Antituberculosis drug\u2010induced liver injury with autoimmune features: facing diagnostic and treatment challenges","volume":"2017","year":"2017","journal-title":"Case Rep Pediatr"},{"key":"lt25451-bib-0034-20240115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5799\/jmid.458463","article-title":"A severe autoimmune\u2010like anti\u2010tuberculosis drug\u2010induced liver injury: case report and review","volume":"8","year":"2018","journal-title":"J Microbiol Infect Dis"},{"key":"lt25451-bib-0035-20240115","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1086\/650576","article-title":"Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment\u2010induced hepatotoxicity","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"lt25451-bib-0036-20240115","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","article-title":"Intravenous N\u2010acetylcysteine improves transplant\u2010free survival in early stage nonacetaminophen acute liver failure","volume":"137","year":"2009","journal-title":"Gastroenterology"},{"key":"lt25451-bib-0037-20240115","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/j.gastro.2015.02.050","article-title":"Population\u2010representative incidence of drug\u2010induced acute liver failure based on an analysis of an integrated health care system","volume":"148","year":"2015","journal-title":"Gastroenterology"},{"key":"lt25451-bib-0038-20240115","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug\u2010induced acute liver failure: results of a U.S. multicenter, prospective study","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"lt25451-bib-0039-20240115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jhep.2016.03.023","article-title":"Usefulness of corticosteroids as first\u2010line therapy in patients with acute severe autoimmune hepatitis","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"lt25451-bib-0040-20240115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MCG.0000000000000805","article-title":"Natural history and treatment outcomes of severe autoimmune hepatitis","volume":"51","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"pt 1","key":"lt25451-bib-0041-20240115","first-page":"1216","article-title":"Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center","volume":"23","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"lt25451-bib-0042-20240115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12072-012-9402-3","article-title":"Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure","volume":"7","year":"2013","journal-title":"Hepatol Int"},{"key":"lt25451-bib-0043-20240115","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/MEG.0000000000000353","article-title":"Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure","volume":"27","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"lt25451-bib-0044-20240115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0168-8278(02)00182-4","article-title":"Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States","volume":"37","year":"2002","journal-title":"J Hepatol"},{"key":"lt25451-bib-0045-20240115","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","article-title":"HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients","volume":"103","year":"1992","journal-title":"Gastroenterology"},{"key":"lt25451-bib-0046-20240115","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.21884","article-title":"The impact of ethnicity on the natural history of autoimmune hepatitis","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"lt25451-bib-0047-20240115","article-title":"Association Between Black Race and Presentation and Liver\u2010related Outcomes of Patients With Autoimmune Hepatitis","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"lt25451-bib-0048-20240115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","article-title":"Antibodies to soluble liver antigen\/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis","volume":"97","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"lt25451-bib-0049-20240115","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","year":"1993","journal-title":"Hepatology"},{"key":"lt25451-bib-0050-20240115","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","year":"1999","journal-title":"J Hepatol"},{"key":"lt25451-bib-0051-20240115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"lt25451-bib-0052-20240115","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1478-3231.2011.02524.x","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute\u2010onset autoimmune hepatitis","volume":"31","year":"2011","journal-title":"Liver Int"},{"key":"lt25451-bib-0053-20240115","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","year":"2009","journal-title":"Hepatology"},{"key":"lt25451-bib-0054-20240115","first-page":"3513206","article-title":"Clinical and pathological characteristics of autoimmune hepatitis with acute presentation","volume":"2018","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"lt25451-bib-0055-20240115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","article-title":"Clinicopathological features of severe and fulminant forms of autoimmune hepatitis","volume":"46","year":"2011","journal-title":"J Gastroenterol"},{"key":"lt25451-bib-0056-20240115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-008-2254-x","article-title":"Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute\u2010onset autoimmune hepatitis","volume":"43","year":"2008","journal-title":"J Gastroenterol"},{"key":"lt25451-bib-0057-20240115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1872-034X.2011.00892.x","article-title":"Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure","volume":"42","year":"2012","journal-title":"Hepatol Res"},{"key":"lt25451-bib-0058-20240115","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/liv.13725","article-title":"Clinical and prognostic associations of liver volume determined by computed tomography in acute liver failure","volume":"38","year":"2018","journal-title":"Liver Int"},{"key":"lt25451-bib-0059-20240115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dld.2009.04.009","article-title":"Autoimmune hepatitis with acute presentation in Japan","volume":"42","year":"2010","journal-title":"Dig Liver Dis"},{"key":"lt25451-bib-0060-20240115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","year":"2006","journal-title":"J Clin Pathol"},{"key":"lt25451-bib-0061-20240115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4254\/wjh.v4.i9.262","article-title":"Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis","volume":"4","year":"2012","journal-title":"World J Hepatol"},{"key":"lt25451-bib-0062-20240115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0676.1984.tb00954.x","article-title":"Acute liver biopsy lesions in early autoimmune (\"lupoid\") chronic active hepatitis","volume":"4","year":"1984","journal-title":"Liver"},{"key":"lt25451-bib-0063-20240115","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/gast.1997.v113.pm9247489","article-title":"A novel histological lesion in glucocorticoid\u2010responsive chronic hepatitis","volume":"113","year":"1997","journal-title":"Gastroenterology"},{"key":"lt25451-bib-0064-20240115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1872-034X.2011.00810.x","article-title":"Proposal of autoimmune hepatitis presenting with acute hepatitis, severe hepatitis and acute liver failure","volume":"41","year":"2011","journal-title":"Hepatol Res"},{"key":"lt25451-bib-0065-20240115","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.2016.267","article-title":"Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria","volume":"30","year":"2017","journal-title":"Mod Pathol"},{"key":"lt25451-bib-0066-20240115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"lt25451-bib-0067-20240115","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1478-3231.2007.01466.x","article-title":"Special stains can distinguish hepatic necrosis with regenerative nodules from cirrhosis","volume":"27","year":"2007","journal-title":"Liver Int"},{"key":"lt25451-bib-0068-20240115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","year":"1971","journal-title":"Q J Med"},{"key":"lt25451-bib-0069-20240115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0016-5085(19)33286-X","article-title":"\u201cLupoid\u201d hepatitis, a nonentity in the spectrum of chronic active liver disease","volume":"63","year":"1972","journal-title":"Gastroenterology"},{"key":"lt25451-bib-0070-20240115","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","year":"1975","journal-title":"Gut"},{"key":"lt25451-bib-0071-20240115","article-title":"Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"lt25451-bib-0072-20240115","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"lt25451-bib-0073-20240115","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"issue":"suppl","key":"lt25451-bib-0074-20240115","first-page":"S4","article-title":"Treatment and prognosis of acute severe autoimmune hepatitis","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"lt25451-bib-0075-20240115","article-title":"Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy","year":"2018","journal-title":"Hepatology"},{"key":"lt25451-bib-0076-20240115","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3748\/wjg.v13.i23.3232","article-title":"Low\u2010dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis","volume":"13","year":"2007","journal-title":"World J Gastroenterol"},{"key":"lt25451-bib-0077-20240115","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"lt25451-bib-0078-20240115","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"lt25451-bib-0079-20240115","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2006.02894.x","article-title":"Clinical characteristics of fulminant\u2010type autoimmune hepatitis: an analysis of eleven cases","volume":"23","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"lt25451-bib-0080-20240115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"lt25451-bib-0081-20240115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long\u2010term pathologic study","volume":"32","year":"2000","journal-title":"Hepatology"},{"key":"lt25451-bib-0082-20240115","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"issue":"suppl 2","key":"lt25451-bib-0083-20240115","first-page":"S67","article-title":"Etiology and prognosis of fulminant hepatitis in adults","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"lt25451-bib-0084-20240115","first-page":"1401","article-title":"Acute liver failure: summary of a workshop","volume":"47","year":"2008","journal-title":"Hepatology"},{"key":"lt25451-bib-0085-20240115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.21.1.78","article-title":"Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis","volume":"21","year":"1980","journal-title":"Gut"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.25451","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lt.25451","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/lt.25451","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201906000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T01:26:50Z","timestamp":1705282010000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201906000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.25451","relation":{},"ISSN":["1527-6465","1527-6473"],"issn-type":[{"value":"1527-6465","type":"print"},{"value":"1527-6473","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]}}}